Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
TERMINATED
NCT06613685
PHASE2/PHASE3

Study of Oral Weekly GS-1720 and GS-4182 Compared With Biktarvy in People With HIV-1 Who Have Not Been Treated

Sponsor: Gilead Sciences

View on ClinicalTrials.gov

Summary

The goal of this clinical study is to learn more about the experimental drugs lepetegravir (formerly GS-1720) (an oral, long-acting integrase strand transfer inhibitor (INSTI)) and lenacapavir pacfosacil (formerly GS-4182) (a prodrug of Lenacapavir (LEN)); to compare the combination of lepetegravir and lenacapavir pacfosacil with the current standard-of-care treatment bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) (Biktarvy), to see if the combination of lepetegravir and lenacapavir pacfosacil is safe and if it works for treating human immunodeficiency virus type 1 (HIV-1) infection in treatment-naive people with HIV-1 (PWH). This study has two phases: Phase 2 and Phase 3. The primary objectives of this study are: Phase 2: To evaluate the efficacy of oral weekly lepetegravir coadministered with lenacapavir pacfosacil versus continuing Biktarvy (BVY) in treatment-naive PWH at Week 24. Phase 3: To evaluate the efficacy of oral weekly lepetegravir/lenacapavir pacfosacil fixed-dose combination (FDC) tablet regimen versus continuing BVY in treatment-naive PWH at Week 48.

Official title: An Operationally Seamless Phase 2/3, Randomized, Active-Controlled Study Evaluating the Safety and Efficacy of an Oral Weekly Regimen of GS-1720 in Combination With GS-4182 Versus Biktarvy in Treatment-Naive People With HIV-1

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

73

Start Date

2024-10-21

Completion Date

2026-03-16

Last Updated

2026-04-15

Healthy Volunteers

No

Conditions

Interventions

DRUG

lepetegravir

Tablets administered orally without regard to food

DRUG

lenacapavir pacfosacil

Tablets administered orally without regard to food

DRUG

Bictegravir/emtricitabine/tenofovir alafenamide

Tablets administered orally without regard to food

DRUG

lepetegravir/lenacapavir pacfosacil FDC

Tablets administered orally without regard to food

DRUG

Placebo to Match BVY

Tablets administered orally without regard to food

DRUG

Placebo to Match GS1720/GS-4182 FDC

Tablets administered orally without regard to food

Locations (58)

UAB 1917 Research Clinic

Birmingham, Alabama, United States

The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center

Torrance, California, United States

Mills Clinical Research

West Hollywood, California, United States

Georgetown University Medical School

Washington D.C., District of Columbia, United States

Midland Florida Clinical Research Center, LLC

DeLand, Florida, United States

Midway Immunology and Research Center

Ft. Pierce, Florida, United States

Floridian Clinical Research, LLC

Miami Lakes, Florida, United States

Orlando Immunology Center

Orlando, Florida, United States

Triple O Research Institute, P.A.

West Palm Beach, Florida, United States

Emory University Hospital Midtown Infectious Disease Clinic

Atlanta, Georgia, United States

Mercer University, Department of Internal Medicine

Macon, Georgia, United States

University of Mississippi Medical Center

Jackson, Mississippi, United States

Saint Michael's Medical Center

Newark, New Jersey, United States

NYU Langone Health Vaccine Center

New York, New York, United States

Medical University of South Carolina (MUSC) Research Nexus

Charleston, South Carolina, United States

St Hope Foundation, Inc.

Bellaire, Texas, United States

Prism Health North Texas, Aids Arms

Dallas, Texas, United States

North Texas Infectious Diseases Consultants, PA

Dallas, Texas, United States

Texas Centers for Infectious Disease Associates

Fort Worth, Texas, United States

UT Health San Antonio

San Antonio, Texas, United States

MultiCare Rockwood Main Clinic

Spokane, Washington, United States

Clinique Médicale L'Actuel

Montreal, Canada

Chronic Viral Illness Service / McGill University Health Centre

Montreal, Canada

Ottawa Hospital Research Institute

Ottawa, Canada

Universitätsklinikum Bonn, Medizinische Klinik und Poliklinik I, Immunologische Studienambulanz

Bonn, Germany

Universitätsmedizin Essen, Universitätsklinikum Essen, Klinik für Dermatologie, Venerologie und Allergologie, HPSTD-Ambulanz

Essen, Germany

ICH Study Center GmbH & Co. KG

Hamburg, Germany

Medizinische Hochschule Hannover, Klinik für Rheumatologie und Immunologie, Gebäude K14

Hanover, Germany

Klinikum rechts der Isar, Technische Universität München, Klinik und Poliklinik für Innere Medizin II

München, Germany

Wojewódzki Szpital Obserwacyjno-Zakaźny im. Tadeusza Browicza

Bydoszcz, Poland

Punkt Zdrowia

Gdansk, Poland

Samodzielny Publiczny Wojewódzki Szpital Zespolony w Szczecinie

Szczecin, Poland

Unidade Local de Saude de Amadora Sinatra EPE, Hospital Prof. Doutor Fernando Fonseca

Amadora, Portugal

Unidade Local de Saúde de Lisboa Ocidental E.P.E. - Hospital Egas Moniz

Lisbon, Portugal

Unidade Local de Saúde de Santo Maria E.P.E. - Hospital Santa Maria

Lisbon, Portugal

Unidade Local de Saúde de Santo António, E.P.E.

Porto, Portugal

Unidade Local de Saúde de São João E.P.E.

Porto, Portugal

HOPE Clinical Research

San Juan, PR, Puerto Rico

Proyecto ACTU

San Juan, PR, Puerto Rico

Institutul National De Boli Infectioase Prof. Dr. Matei Bals

Bucharest, Romania

Spitalul Clinic De Urgenta Prof Dr Agrippa Ionescu

Bucharest, Romania

Spitalul Clinic De Boli Infectioase Cluj-Napoca

Cluj-Napoca, Romania

Spitalul Clinic de Boli Infectioase Constanta

Constanța, Romania

Clinical Hospital of Infectious Diseases and Pneumophysiology Dr. Victor Babes Timisoara

Timișoara, Romania

JOSHA Research

Bloemfontein, South Africa

Durban International Clinical Research Site, Enhancing Care Foundation

Durban, South Africa

Synergy Biomed Research Institute

East London, South Africa

CRISMO Research Center

Germiston, South Africa

WITS RHI Research Centre

Johannesburg, South Africa

Clinical Research Institute of South Africa (CRISA)

KwaZulu-Natal, South Africa

FPD Ndevana Community Research Site

Ndevana, South Africa

The Aurum Institute Tembisa Clinic 4

Tembisa, South Africa

Hospital Clinic de Barcelona

Barcelona, Spain

Hospital Clinico San Carlos

Madrid, Spain

Hospital Universitario Fundación Jiménez Díaz

Madrid, Spain

Hospital Universitario Virgen de la Victoria

Málaga, Spain

Hospital Universitario Alvaro Cunqueiro

Pontevedra, Spain

Hospital Arnau de Vilanova de Valencia

Valencia, Spain